These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
393 related items for PubMed ID: 22738429
1. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors. Saw CL, Hannach B, Petrazsko T, Nickerson P. Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429 [Abstract] [Full Text] [Related]
2. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury. Hashimoto S, Nakajima F, Kamada H, Kawamura K, Satake M, Tadokoro K, Okazaki H. Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042 [Abstract] [Full Text] [Related]
3. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Reil A, Keller-Stanislawski B, Günay S, Bux J. Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261 [Abstract] [Full Text] [Related]
4. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007). Keller-Stanislawski B, Reil A, Günay S, Funk MB. Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122 [Abstract] [Full Text] [Related]
5. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS. Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778 [Abstract] [Full Text] [Related]
6. Transfusion-related acute lung injury (TRALI): a review of investigations by the National Tissue Typing Laboratory of cases reported in New Zealand since June 2004. Dunn P, Dinesh D. N Z Med J; 2008 Jun 20; 121(1276):42-7. PubMed ID: 18574508 [Abstract] [Full Text] [Related]
7. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience. Sachs UJ, Link E, Hofmann C, Wasel W, Bein G. Transfus Med; 2008 Dec 20; 18(6):348-54. PubMed ID: 19140817 [Abstract] [Full Text] [Related]
8. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines. Lucas G, Win N, Calvert A, Green A, Griffin E, Bendukidze N, Hopkins M, Browne T, Poles A, Chapman C, Massey E. Vox Sang; 2012 Jul 20; 103(1):10-7. PubMed ID: 22150747 [Abstract] [Full Text] [Related]
9. How much residual plasma may cause TRALI? Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, Wallis JP. Transfus Med; 2008 Oct 20; 18(5):276-80. PubMed ID: 18937733 [Abstract] [Full Text] [Related]
10. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies. Curtis BR, McFarland JG. Crit Care Med; 2006 May 20; 34(5 Suppl):S118-23. PubMed ID: 16617255 [Abstract] [Full Text] [Related]
11. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services. Lin Y, Saw CL, Hannach B, Goldman M. Transfusion; 2012 Mar 20; 52(3):567-74. PubMed ID: 21895676 [Abstract] [Full Text] [Related]
12. Transfusion-related acute lung injury reports in the Netherlands: an observational study. van Stein D, Beckers EA, Sintnicolaas K, Porcelijn L, Danovic F, Wollersheim JA, Brand A, van Rhenen DJ. Transfusion; 2010 Jan 20; 50(1):213-20. PubMed ID: 19694998 [Abstract] [Full Text] [Related]
13. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations. Odent-Malaure H, Quainon F, Ruyer-Dumontier P, Ducroz S, Verdier P, Voitellier E, Raynal MF, Fromont P, Muller JY, Rebibo D, Absi L, Garraud O. Clin Dev Immunol; 2005 Dec 20; 12(4):243-8. PubMed ID: 16584109 [Abstract] [Full Text] [Related]
14. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report. Muro M, Rivera J, Botella C, Campillo JA, Ferrer F, Alvarez-López MR. Transfus Apher Sci; 2008 Jun 20; 38(3):209-12. PubMed ID: 18462996 [Abstract] [Full Text] [Related]
15. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets. Eder AF, Dy BA, O'Neill EM. Transfusion; 2016 Jun 20; 56(6 Pt 2):1608-15. PubMed ID: 26830063 [Abstract] [Full Text] [Related]
16. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors. Porretti L, Cattaneo A, Coluccio E, Mantione E, Colombo F, Mariani M, Bottelli G, Mazzucchelli S, Pappalettera M, Speranza T, Migliari M, Cambié G, Prati D, Rebulla P. Blood Transfus; 2012 Jul 20; 10(3):351-9. PubMed ID: 22395353 [Abstract] [Full Text] [Related]
18. Underdiagnosing of antibody-mediated transfusion-related acute lung injury: evaluation of cellular-based versus bead-based techniques. van Stein D, Beckers EA, Peters AL, Porcelijn L, Middelburg RA, Lardy NM, van Rhenen DJ, Vlaar AP. Vox Sang; 2016 Jul 20; 111(1):71-8. PubMed ID: 26991993 [Abstract] [Full Text] [Related]
19. Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI. Middelburg RA, Beckers EA, Porcelijn L, Lardy N, Wiersum-Osselton JC, Schipperus MR, Vrielink H, Briët E, van der Bom JG. Transfus Med; 2012 Apr 20; 22(2):128-32. PubMed ID: 22380759 [Abstract] [Full Text] [Related]